Who invested in Biorelate?
Biorelate's investors include Maven Capital Partners, Triple Point Ventures, YFM Equity Partners and Northern Powerhouse Investment Fund.

United Kingdom · Series A startup
Funding summaryUpdated 26 Oct 2026
$15Mraised across 3 rounds since 2022, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Source recorded
Biorelate filed 3 raises, $17M in all. Filings say how much was sold and to how many investors; they never name the investors.
From Biorelate's own website: 1 founder, 6 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Biorelate's investors include Maven Capital Partners, Triple Point Ventures, YFM Equity Partners and Northern Powerhouse Investment Fund.
Biorelate has raised $15M across 3 rounds since 2022.
Biorelate's most recent round, $3.5M, was in Aug 2026.
Biorelate's largest round on record is $7.8M (Series A), in Nov 2022.
Biorelate's first round on record, in Nov 2022, was backed by Maven Capital Partners, Triple Point Ventures and YFM Equity Partners and 1 others.
Biorelate's latest named round is a Series A, in Nov 2022.
Biorelate is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.